These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2166921)

  • 1. Behavioural effects in gerbils of the 5-HT3 receptor antagonists, BRL 43694 and ICS 205-930, under circumstances of high and low light intensity.
    Cutler MG
    Neuropharmacology; 1990 Jun; 29(6):515-20. PubMed ID: 2166921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic administration of the 5-HT3 receptor antagonist BRL 43694; effects on reflex epilepsy and social behaviour of the Mongolian gerbil.
    Cutler MG; Piper DC
    Psychopharmacology (Berl); 1990; 101(2):244-9. PubMed ID: 2161551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ethological study of the effects of buspirone and the 5-HT3 receptor antagonist, BRL 43694 (granisetron) on behaviour during social interactions in female and male mice.
    Cutler MG
    Neuropharmacology; 1991 Apr; 30(4):299-306. PubMed ID: 1649417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acute administration of the 5-HT3 receptor antagonist, BRL 46470A, on the behaviour of mice in a two compartment light-dark box and during social interactions in their home cage and an unfamiliar neutral cage.
    Gao B; Cutler MG
    Neuropharmacology; 1992 Aug; 31(8):743-8. PubMed ID: 1356251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sub-chronic treatment with chlordiazepoxide, buspirone and the 5-HT3 receptor antagonist, BRL 46470, on the social behaviour of mice.
    Gao B; Cutler MG
    Neuropharmacology; 1992 Mar; 31(3):207-13. PubMed ID: 1630589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chlordiazepoxide, buspirone and the 5-HT3 receptor antagonist, BRL 46470, on the behaviour of oestrous and dioestrous female mice when encountering male partners.
    Gao B; Cutler MG
    Neuropharmacology; 1993 Oct; 32(10):969-75. PubMed ID: 7905193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models.
    Artaiz I; Romero G; Zazpe A; Monge A; Calderó JM; Roca J; Lasheras B; Del Río J
    Psychopharmacology (Berl); 1995 Jan; 117(2):137-48. PubMed ID: 7753959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of granisetron, ICS 205-930 and ondansetron on the visceral pain reflex induced by duodenal distension.
    Moss HE; Sanger GJ
    Br J Pharmacol; 1990 Jul; 100(3):497-501. PubMed ID: 2167734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 5-hydroxytryptamine 3 receptor antagonists on gastrointestinal motor activity in conscious dogs.
    Yoshida N; Mizumoto A; Iwanaga Y; Itoh Z
    J Pharmacol Exp Ther; 1991 Jan; 256(1):272-8. PubMed ID: 1846418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that the amygdala is involved in the disinhibitory effects of 5-HT3 receptor antagonists.
    Higgins GA; Jones BJ; Oakley NR; Tyers MB
    Psychopharmacology (Berl); 1991; 104(4):545-51. PubMed ID: 1664112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron).
    Sanger GJ; Nelson DR
    Eur J Pharmacol; 1989 Jan; 159(2):113-24. PubMed ID: 2540014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse.
    Costall B; Kelly ME; Naylor RJ; Onaivi ES; Tyers MB
    Br J Pharmacol; 1989 Feb; 96(2):325-32. PubMed ID: 2522335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT3 receptor antagonists inhibit morphine-induced stimulation of mesolimbic dopamine release and function in the rat.
    Pei Q; Zetterström T; Leslie RA; Grahame-Smith DG
    Eur J Pharmacol; 1993 Jan; 230(1):63-8. PubMed ID: 8381355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic BRL 43694, a selective 5-HT3 receptor antagonist, fails to alter the number of spontaneously active midbrain dopamine neurons.
    Ashby CR; Jiang LH; Wang RY
    Eur J Pharmacol; 1990 Jan; 175(3):347-50. PubMed ID: 2157603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actions of 5-hydroxytryptophan to inhibit and disinhibit mouse behaviour in the light/dark test.
    Cheng CH; Costall B; Kelly ME; Naylor RJ
    Eur J Pharmacol; 1994 Apr; 255(1-3):39-49. PubMed ID: 7913044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRL 46470 potently antagonizes neural responses activated by 5-HT3 receptors.
    Newberry NR; Watkins CJ; Sprosen TS; Blackburn TP; Grahame-Smith DG; Leslie RA
    Neuropharmacology; 1993 Aug; 32(8):729-35. PubMed ID: 8413836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT3 receptor antagonists attenuate dopamine-induced hyperactivity in the rat.
    Costall B; Domeney AM; Naylor RJ
    Neuroreport; 1990 Sep; 1(1):77-80. PubMed ID: 1966601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effects of 5HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat.
    File SE; Johnston AL
    Psychopharmacology (Berl); 1989; 99(2):248-51. PubMed ID: 2552485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT3 receptor antagonists inhibit sensory neuropeptide release from the rat spinal cord.
    Saria A; Javorsky F; Humpel C; Gamse R
    Neuroreport; 1990 Oct; 1(2):104-6. PubMed ID: 1717037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 5-HT3 receptor antagonists on binding and function of mouse and human GABAA receptors.
    Klein RL; Sanna E; McQuilkin SJ; Whiting PJ; Harris RA
    Eur J Pharmacol; 1994 Jul; 268(2):237-46. PubMed ID: 7957645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.